Genpact falls after results, guidance The shares are down over 15.8% at time of writing to $14.50. At that price, next support is at the fresh 52-week low set this morning at $13.68. Resistance is at the session high at $15.50. The $14 level on a multi-year chart basis is an important support. A break below it could lead to additional selling pressure.